Generic pressure forces GSK site closure
GlaxoSmithKline (GSK) has proposed that it will close its facility in Dartford, UK in 2013, as the loss of patents for key drugs makes its operation uneconomical.
GlaxoSmithKline (GSK) has proposed that it will close its facility in Dartford, UK in 2013, as the loss of patents for key drugs makes its operation uneconomical.
SAFC's Mike Harris explains bench top continuous processing at this year's CPhI
A Terre Haute, US resident has filed a lawsuit against Pfizer alleging that the company “negligently or recklessly” maintained its dam, resulting in the release of PCB.
A Californian appeals court ruling may have altered product liability in the state, which could lead to numerous court cases being brought against big pharma.
Robert Sexauer, CEO of biopharmaceuticals group RCP Therapeutics, says the R&D investment deal signed with FirstPoint Biotech shows the attractiveness of the firm’s nano-medical pipeline, particularly given the current economic climate.